Delivery Order SPE2DB20D3505-SPE2DB23FU5K5
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $1,834.55. The contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. This award is part of the larger $999,999,999 IDC held by Cencora, Inc. with the DLA, which serves as the primary vehicle for the company to deliver a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty pharmaceutical product. The $9,962.70 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on April 2, 2024, with a completion date of April 3, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds significant Indefinite Delivery Contracts...
- This federal contract award, with a ceiling value of $13,518.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The contract covers the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty pharmaceutical product, to support military...
- This federal contract award, valued at $1,947.86, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract has an ultimate completion date of October 10, 2023 and is a Firm Fixed Price Delivery Order. The award was made without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award, valued at $1,527.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 28, 2023. This award is not associated with a set-aside designation, indicating it was awarded through full and open...
- This federal contract award, valued at $1,097.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distribution company and subsidiary of Cencora, Inc. The contract involves the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a specialty medication. The award has an ultimate completion date of December 29, 2023 and is a firm fixed-price delivery order contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $5,028.23 for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00,...
- This federal contract award, valued at $3,345.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medical product. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., the parent company. This contract is a delivery order, with a firm fixed-price pricing type and an...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,061.92 delivery order contract is for the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML and has a completion date of February 23, 2024. The contract is a firm fixed price delivery order and was not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award, valued at $7,637.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication, under a firm fixed-price delivery order. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB23FU5K5Delivery Order
This federal contract award, valued at $1,239.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty pharmaceutical product. The award is a Delivery Order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs demonstrate Amerisourcebergen's extensive capabilities in meeting the diverse pharmaceutical and medical supply needs of multiple government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/8/23 |